CONFIRM: Magnetic Resonance Guided Radiation Therapy
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Mantle Cell Lymphoma
Related studies linked through entity extraction aliases.
First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Ketogenic Diet in Patients With Untreated Low Tumor Burden Mantle Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
- Status
- RECRUITING
- Phase
- PHASE1
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Study of LUCAR-20S in Patients With R/R NHL
- Status
- TERMINATED
- Phase
- PHASE1
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)
- Status
- UNKNOWN
- Phase
- N/A
Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment
- Status
- COMPLETED
- Phase
- PHASE2
A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results.
- Status
- UNKNOWN
- Phase
- N/A
A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- N/A
ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1